MONTPELLIER, France

Prisca Boisguerin

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Universitè De Montpellier. Active years: 2024.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Prisca Boisguerin: Innovator in Cell-Penetrating Peptides

Introduction

Prisca Boisguerin is a notable inventor based in Montpellier, France. She has made significant contributions to the field of biotechnology, particularly in the development of peptides that can penetrate cell membranes. Her innovative work has the potential to advance various applications in medicine and drug delivery.

Latest Patents

Prisca Boisguerin holds a patent for "Peptides for use as cell-penetrating peptides." This invention relates to new peptides comprising an amino acid sequence LL-[X]n-LL, where X is selected from R, L, and W, and n ranges from 10 to 12. The peptide structure includes 4 R, 4 L, and between 2 and 4 W. Additionally, the invention encompasses nanoparticles that incorporate these peptides along with a cargo molecule, expanding their utility in therapeutic applications.

Career Highlights

Throughout her career, Boisguerin has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université de Montpellier. Her research has focused on the intersection of peptide chemistry and cellular biology, leading to groundbreaking discoveries in the field.

Collaborations

Prisca has collaborated with notable colleagues, including Sébastien Deshayes and Karidia Konate. These partnerships have fostered a collaborative environment that enhances the innovation process and drives research forward.

Conclusion

Prisca Boisguerin's contributions to the field of cell-penetrating peptides exemplify her dedication to advancing biotechnology. Her innovative patents and collaborative efforts position her as a key figure in the scientific community.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…